SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix ($OCUL) is heavily trending amid high anticipation for imminent topline data from its Phase 3 superiority trial of Axpaxli in wet AMD, with the community widely expecting positive results to drive significant upside. Adding to the bullish sentiment, speculation of a sweetened Sanofi buyout offer, following a rejected $16/share bid, is fueling active discussion around potential acquisition prices and a forthcoming short squeeze.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM Integrated Shipping Services is trending as Hapag-Lloyd confirmed an all-cash acquisition offer for $35 per share, sparking fervent community discussion around arbitrage opportunities and the potential for a massive short squeeze. Shareholders are closely watching for regulatory approvals, particularly from the Israeli government, while also anticipating potential dividends before the deal's expected completion.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending as recent softer inflation data, flat retail sales, and rising jobless claims intensify community expectations for earlier Fed rate cuts, driving a rally amid a 'flight to safety' narrative. However, fierce debate persists over the reliability of economic data and the long-term trajectory for bond yields.

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Mannkind Corp

Mannkind Corp is trending after receiving FDA approval for an updated Afrezza label aimed at simplifying dosing guidance and boosting adoption, with the community actively debating its impact alongside the highly anticipated pediatric approval and the ongoing market launch in India.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Infleqtion Inc. - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X (CCCX) is trending as its merger with quantum technology leader Infleqtion nears, with shares expected to trade as INFQ on the NYSE following shareholder approval and an exceptionally low redemption rate. The community is highly bullish on Infleqtion's validated technology, including recent NASA and U.S. DOE contracts, and anticipates substantial upside from its limited post-merger public float, viewing it as significantly undervalued compared to sector peers.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is drawing significant attention ahead of its anticipated Phase 3 data release for COMP360 in treatment-resistant depression, a pivotal event that has the community actively debating its potential as a first-to-market psychedelic therapy alongside new FDA clearance for PTSD trials. The broader sector watches closely for implications on regulatory pathways and commercial viability.

SSR Mining, Inc. is a gold company with assets located in four jurisdictions: the USA, Turkiye, Canada, and Argentina, which engages in the operation, acquisition, exploration and development of precious metal resource properties. The firm produces gold ore as well as copper, silver, lead and zinc concentrates. It operates through the following business segments: Copler, Marigold, Seabee and Puna. The Copler, Marigold, Seabee, and Puna segments represent its four operating mine sites. The company was founded on December 11, 1946 and is headquartered in Denver, CO.

SSR Mining Inc

SSR Mining is gaining traction ahead of its highly anticipated earnings, with the community discussing expectations for a significant EPS increase driven by robust gold prices and strategic mine contributions, despite lingering concerns over the Copler mine incident.

BitGo Holdings, Inc. provides cryptocurrency custody solutions. It offers self-custody wallet, qualified custody, liquidity and prime, and infrastructure-as-a-service. The company was founded by Michael Belshe in 2013 and is headquartered in Palo Alto, CA.

BitGo Holdings Inc. - Ordinary Shares - Class A

BitGo is a hot topic following multiple institutional analyst initiations, with firms largely optimistic about its "monopoly" in digital asset custody and infrastructure, while community discussion intensely debates its current valuation amidst sharp volatility since its public offering.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

Norwegian Cruise Line Holdings (NCLH) is buzzing after activist investor Elliott Investment Management revealed a substantial stake, aiming to drive performance improvements and help the company catch up to rivals. Community discussions are highly polarized, with many expressing optimism for a turnaround under new leadership while others accuse institutional downgrades of manipulating the stock amidst these strategic shifts.

B2Gold Corp. is an exploration company, which engages in the acquisition and development of mineral properties. It operates through the following segments: Fekola Mine, Fekola Regional, Masbate Mine, Otjikoto Mine, Goose Project, Other Mineral Properties, and Corporate and Other. The Fekola Regional segment consists of Bantako North, Menankoto, Dandoko, and Bakolobi properties. The Other Mineral Properties segment focuses on the company interests in mineral properties which are at various stages of exploration and evaluation. The Corporate and Other segment includes the corporate operations. The company was founded by Mark Anthony Corra, Thomas A. Garagan, Clive Thomas Johnson, and Roger Thomas Richer on November 30, 2006 and is headquartered in Vancouver, Canada.

B2gold Corp

B2Gold is trending amid a significant surge in gold prices, with the community widely discussing the stock's perceived undervaluation despite increased production from its newly commercial Goose Mine, as investors anticipate strong earnings and question its lagging performance against the metal's rally.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Longevity Biotech Stocks Surge as $27 Trillion Healthcare Shift Favors Cell Restoration

Longevity Biotech Stocks Surge as $27 Trillion Healthcare Shift Favors Cell Restoration Longevity Biotech Stocks Surge as $27 Trillion Healthcare Shift Favors Cell Restoration PR Newswire VANCOUVER...

Lineage Cell (LCTX) Reports Q3 Loss, Tops Revenue Estimates

Lineage Cell (LCTX) delivered earnings and revenue surprises of -550.00% and +40.34%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Strength Seen in Wave Life Sciences (WVE): Can Its 11.4% Jump Turn into More Strength?

Wave Life Sciences (WVE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Lineage Cell (LCTX) Reports Q2 Loss, Beats Revenue Estimates

Lineage Cell (LCTX) delivered earnings and revenue surprises of +50.00% and +75.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Nuvation Bio Inc. (NUVB) Reports Q2 Loss, Beats Revenue Estimates

Nuvation Bio (NUVB) delivered earnings and revenue surprises of 0.00% and +93.32%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Brookdale Senior Living (BKD) Reports Q2 Loss, Misses Revenue Estimates

Brookdale (BKD) delivered earnings and revenue surprises of -28.57% and -0.64%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Lineage Cell (LCTX) Reports Q1 Loss, Lags Revenue Estimates

Editas Medicine (EDIT) Reports Q1 Loss, Tops Revenue Estimates

U.S. stocks were on the backfoot on Wednesday as the all-important earnings from Nvidia Corp. (<a class="mention" data-mention="$NVDA" data-symbol-id="NVDA" href="https://stocktwits.com/symbol/NVDA" target="_blank">$NVDA</a>) looms large. Given hyped up expectations, the artificial intelligence stalwart has to issue not merely strong guidance but "insane" guidance that's not yet priced in, said LPLFinancial Chief Global Strategist Quincy Krosby.Ahead of the Nvidia's earnings due after the market close, the following stocks are eliciting most bearish sentiment from the retail crowd:Williams-Sonoma, Inc. (<a class="mention" data-mention="$WSM" data-symbol-id="WSM" href="https://stocktwits.com/symbol/WSM" target="_blank">$WSM</a>)Shares of San Francisco, California-based omni-channel specialty retailer of home products, soared to a record high following a beat-and-raise quarter.&nbsp;Retail largely ignored the positive results and the stock strength and fretted over valuation.&nbsp;<stembedurl>https://stocktwits.com/FetchDog/message/593355051</stembedurl>XP, Inc. (<a class="mention" data-mention="$XP" data-symbol-id="XP" href="https://stocktwits.com/symbol/XP" target="_blank">$XP</a>)&nbsp;XP shares fell over 5% after the Brazilian financial services company reported a double miss for the third quarter. Traders largely ignored a new share repurchase agreement announced by the company.Lineage Cell Therapeutics, Inc. (<a class="mention" data-mention="$LCTX" data-symbol-id="LCTX" href="https://stocktwits.com/symbol/LCTX" target="_blank">$LCTX</a>)Micro-cap clinical-stage biopharma Lineage Cell Therapeutics announced that it entered into definitive agreements with certain healthcare focused institutional investors and with Broadwood Partners, L.P. for raising up to $66 million in a registered direct offering of common stocks and warrants to purchase common stock. The stock was down over 30% at last check.Star Bulk Carriers Corp. (<a class="mention" data-mention="$SBLK" data-symbol-id="SBLK" href="https://stocktwits.com/symbol/SBLK" target="_blank">$SBLK</a>)Greek shipping company Star Bulk Carriers has seen its stock fall over 4.5% as traders digested its mixed earnings report released Tuesday after the close. Incidentally, peer ZIM Integrated Shipping Services Ltd. (<a class="mention" data-mention="$ZIM" data-symbol-id="ZIM" href="https://stocktwits.com/symbol/ZIM" target="_blank">$ZIM</a>) reported a double beat.&nbsp;e.l.f. Beauty, Inc. (<a class="mention" data-mention="$ELF" data-symbol-id="ELF" href="https://stocktwits.com/symbol/ELF" target="_blank">$ELF</a>)Shares of Oakland, California-based e.l.f. Beauty, a maker of cosmetics and skincare products, shed over 9% after short-seller Carson Block's Muddy Waters Research said it is short on the stock.&nbsp;"We believe it's overstating revenue, profits, inventory," the firm <a target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/muddywatersre/status/1859273379145978200">said</a> in a post on X, adding that about 80% of its products are imported. Import data showed that the company's imports crashes by two-thirds, three quarters ago and haven't recovered since then, it added.The firm sees revenue overstatement to the tune of $135 million-$190 million.For updates and corrections email <a target="_blank" rel="noopener noreferrer nofollow" href="mailto:newsroom@stocktwits.com">newsroom@stocktwits.com</a>&nbsp;Read Next:<a href="https://stocktwits.com/news-articles/markets/equity/these-5-stocks-elicited-most-bullish-reactions-from-retail-mid-day-wednesday-novemeber-20/cJ46o5JRXJ"> 5 Stocks Retail Investors Are Most Bullish On At Mid-Day&nbsp;</a>

S&P 500 Index trades listlessly ahead of Nvidia earnings. 

5 Stocks Retail Investors Are Most Bearish On At Mid-Day

Disappointing retail earnings and concerns about bloated valuations are weighing down on retail sentiment toward some stocks.

Equity

Lineage Cell Therapeutics, Inc. operates as a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer. The company's programs are based on two core proprietary technology platforms: cell replacement and cell and drug delivery. Its cell replacement platform creates new cells and tissues with its pluripotent and progenitor cell technologies. The company's cell and drug delivery programs are based upon its proprietary HyStem cell and drug delivery matrix technology. It engages in the research and development of regenerative medicine or therapeutic products for advancement in the field of oncology, orthopedics, retinal and neurological diseases and disorders, blood and vascular system diseases and disorders, blood plasma volume expansion, diagnostic products for the early detection of cancer and hydrogel products that may be used in surgery and products for human embryonic stem cell research. The company was founded by Judith Segall, Hal Sternberg, Paul E. Segall and Harold D. Waitz on November 30, 1990 and is headquartered in Carlsbad, CA.

Lineage Cell Therapeutics Inc

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

Current Price	$1.66
Prev Close	$1.70
Open	$1.71
Dividend Yield	0.00%
50-Day Moving Average	$1.69
Beta	1.14
Avg. Volume	1.03M
PE Ratio	-5.59

52-Week High	$2.09
52-Week Low	$0.3651
Market Capitalization	$382.34M
EPS (Annual)	-$0.093
Price to Book	17.35
Revenue Per Employee	$123,363.64

LCTX
Lineage Cell Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LCTX News

LCTXLineage Cell Therapeutics Inc